Near-infrared (NIR) light therapy, with or without low-dose methylene blue (MB), has been shown in experimental and early clinical contexts to enhance mitochondrial electron transport, improve ATP production, and reduce oxidative stress in neural tissue [28]
It does not act on appetite, satiety, or metabolism in a way relevant to weight management
Learn more: What is GLP-1
In this study, we investigated the skin toxicity of several copper compounds using cell-based in vitro tests and evaluated the expression of various cytokines at genomic and proteomic levels to discover irritancy biomarkers suitable for copper compounds
IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity:a randomised, placebo-controlled, multiple ascending dose phase 1b study